A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/07/2006	WO2006094934A8 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
12/07/2006	WO2006094627A3 Use of hydroxy tetrahydro-naphtalene derivates for the treatment of respiratory diseases
12/07/2006	WO2006093786A3 Scopolamine sublingual spray
12/07/2006	WO2006089494A9 Osmotic device containing amantadine and an osmotic salt
12/07/2006	WO2006089141A3 Antibodies against cxcr4 and methods of use thereof
12/07/2006	WO2006089106A3 Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
12/07/2006	WO2006086978A3 Use of deuterated n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamides and the pharmaceutically acceptable salts thereof, and medicaments containing said compounds
12/07/2006	WO2006085890A3 Anti-hiv quinuclidine compounds
12/07/2006	WO2006085330A3 Use of protein tyrosine kinase inhibitors for the treatment of leiomyomas
12/07/2006	WO2006084882A3 Substituted 4-(indol-3-yl)quinazolines and their use
12/07/2006	WO2006084475A3 A tablet comprising a fibrate
12/07/2006	WO2006083257A3 Drug delivery apparatus utilizing cantilever
12/07/2006	WO2006081351A3 Variable tint cosmetics
12/07/2006	WO2006079923A3 Form iv crystalline celecoxib
12/07/2006	WO2006078998A3 Methods and compositions for decreasing saliva production
12/07/2006	WO2006078606A3 Ati receptor antagonists for treating vascular inflammation
12/07/2006	WO2006077584A3 New crystalline forms of aripiprazole
12/07/2006	WO2006075094A3 Purine derivatives compositions containing the same and use thereof against cancer
12/07/2006	WO2006074426A3 Cxcr4 antagonists for the treatment of hiv infection
12/07/2006	WO2006073430A3 Therapeutic delivery system comprising a high molecular weight peg-like compound
12/07/2006	WO2006072347A3 Alkinyl-substituted thiophenes
12/07/2006	WO2006068954A3 PYRAZOLO[1,5-A]PYRIMIDINE ADENOSINE A2a RECEPTOR ANTAGONISTS
12/07/2006	WO2006068933A3 Mitotic kinesin inhibitors
12/07/2006	WO2006068905A3 Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
12/07/2006	WO2006068760A3 Anti-inflammatory pyrazolopyrimidines
12/07/2006	WO2006065751A3 Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
12/07/2006	WO2006063215A3 Methods and compositions for the treatment of pulmonary hypertension of the newborn
12/07/2006	WO2006055831A3 Kinase inhibitors
12/07/2006	WO2006054308A3 Stable atorvastatin formulations
12/07/2006	WO2006053903A3 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors
12/07/2006	WO2006053039A3 Hydroxybenzoate salts of metanicotine compounds
12/07/2006	WO2006053031A3 Photocrosslinkable poly(caprolactone fumarate)
12/07/2006	WO2006050045A3 Inhibitors of jun n-terminal kinases for treating glaucomatous retinopathy and ocular diseases
12/07/2006	WO2006044362A3 N-sulfonylpiperidine cannabinoid receptor 1 antagonists
12/07/2006	WO2006041808A3 Tafi inhibitors and their use to treat pulmonary fibrosis
12/07/2006	WO2006037335A3 Use of compounds for the prevention of drug-induced cell toxicity
12/07/2006	WO2006032026A3 Long acting injectable crystal formulations of estradiol metabolites and methods of using same
12/07/2006	WO2006030304A3 Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof
12/07/2006	WO2006029245A3 Compositions and methods relating to novel compounds and targets thereof
12/07/2006	WO2006023659A3 Novel polymorphs of azabicyclohexane
12/07/2006	WO2006005507A8 Pharmaceutical composition of piperazine derivatives
12/07/2006	WO2005115405A8 Methods for treating or preventing restenosis and other vascular proliferative disorders
12/07/2006	WO2005115360A3 Formulations of anti-pain agents and methods of using the same
12/07/2006	WO2005112919A8 Self-immolative linkers and drug conjugates
12/07/2006	WO2005112919A2 Self-immolative linkers and drug conjugates
12/07/2006	WO2005110464A3 Irx5 inhibition as treatment for hyperproliferative disorders
12/07/2006	WO2005100350A8 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
12/07/2006	WO2005086697A3 Materials for medical implants and occlusive devices
12/07/2006	WO2005081881A3 Anxiolytic treatment by inhibition of a polysialyltransferase
12/07/2006	WO2005076743A3 Disaccharide molecules and derivatives thereof and methods of using same
12/07/2006	WO2005067546A3 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
12/07/2006	WO2005056523A3 Methodology for preparing combinatorial libraries based upon a bicyclic scaffold
12/07/2006	WO2005055926A3 Amelioration of cataracts, macular degeneration and other ophthalmic diseases
12/07/2006	WO2005046574A3 Compositions containing melon extracts
12/07/2006	WO2004071435A3 Enhanced Bioavailability Using Laser Resonant Homogenization
12/07/2006	WO2002102129A3 Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product
12/07/2006	US20060276664 biodegradable surfactants
12/07/2006	US20060276650 Pyrazole compounds
12/07/2006	US20060276645 Novel carboxylic acid derivatives, their preparation and use
12/07/2006	US20060276642 Compounds to treat Alzheimer's disease
12/07/2006	US20060276641 Heating reaction mixture containing 11-chlorodibenzo[b,f][1,4]thiazepine and 1-(2-hydroxyethoxy)ethyl piperazine, potassium bicarbonate, and potassium iodide in solvent; thin layer chromatography
12/07/2006	US20060276552 Methods and devices for non-invasive cerebral and systemic cooling
12/07/2006	US20060276551 Exo-S-Mecamylamine Formulation and Use in Treatment
12/07/2006	US20060276550 Topical compositions of ketamine and butamben and methods of their use
12/07/2006	US20060276549 Combination and use of drugs
12/07/2006	US20060276548 Inhibitors of endo-exonuclease activity for treating cancer
12/07/2006	US20060276547 Methods of treating cancer with HDAC inhibitors
12/07/2006	US20060276546 Uses of Prostacyclin Analogs
12/07/2006	US20060276545 Polyhydroxy phenols and their use in binding p-selectin
12/07/2006	US20060276544 Containing 0.15-0.03% isobutylglutarric acid
12/07/2006	US20060276543 Characterized by X-ray powder diffraction peaks at about 5.8, 18.4, 19.2, 20.7, and 23.7 degrees 2 theta +-0.2 degrees 2 theta, comprising crystallizing the pregabalin from a mixture of acetonitrile and an alcohol; use as pharmaceutical dosage form of drug with targeted release profile
12/07/2006	US20060276542 Methods for treating functional bowel disorders using alpha2 subunit calcium channel modulators with smooth muscle modulators
12/07/2006	US20060276540 Selective androgen receptor modulators
12/07/2006	US20060276539 selective androgen receptor modulator (SARM); sexual dysfunction hypogonadism, sarcopenia, osteopenia, osteoporosis, an alteration in cognition and mood, depression, anemia, hair loss, obesity
12/07/2006	US20060276538 Metal carnitine chelates
12/07/2006	US20060276537 Use of ladostigil for the treatment of multiple sclerosis
12/07/2006	US20060276536 Cancer treatment using curcumin derivatives
12/07/2006	US20060276535 )-{3-[4-(2-Ethylamino-ethoxy)-3,5-diiodo-benzoyl]-benzofuran-2-yl}-acetic acid sec-butyl ester; amiodarone derivatives; congestive heart failure, ischemic cardiomyopathy, atrial fibrillation, ventricular tachycardia; side effect reduction: pharmacolkinetics, oral bioavailability, nontoxic
12/07/2006	US20060276534 Methods of decreasing calcification
12/07/2006	US20060276533 Compounds and methods for the treatment or prevention of Flavivirus infections
12/07/2006	US20060276532 2-Cyano-4'-[3-(propane-2-sulfonylamino)-thiophen-2-yl]-biphenyl-4-carboxylic acid; schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, Parkinson's disease, or depression; antipsychotics, antidepressants
12/07/2006	US20060276531 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
12/07/2006	US20060276530 AMPO spin traps
12/07/2006	US20060276529 Use of plasma membrane calcium atpase (pmca) inhibitors for inhibiting sperm mobility
12/07/2006	US20060276528 Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
12/07/2006	US20060276527 Combination therapies for the treatment of cancer
12/07/2006	US20060276526 Crystalline Form of Telmisartan Sodium
12/07/2006	US20060276525 Processes of preparing highly pure telmisartan form A, suitable for pharmaceutical compositions
12/07/2006	US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors
12/07/2006	US20060276523 Nitoroxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
12/07/2006	US20060276522 Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
12/07/2006	US20060276521 e.g. N-{4-[2-(4-{[amino(imino)methyl]amino}phenyl)ethyl]-1,3-thiazol-2-yl}acet-amide; vascular adhesion protein (semicarbazide sensitive amine oxidase) inhibitor; antidiabetic, hypotensive agent; non-insulin dependent diabetis obesity, retinopathy complications, atherosclerosis, macular edema
12/07/2006	US20060276520 Rhodanine derivatives and pharmaceutical compositions containing them
12/07/2006	US20060276519 Thiazole derivatives for treating ppar related disorders
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276517 Non-systemic control of parasites
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276515 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same
12/07/2006	US20060276514 Tyrosine kinase inhibitors
12/07/2006	US20060276513 Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H- benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester

1 ... 3975 3976 3977 3978 3979 3980 3981 3982 3983 3984 3985 3986 3987 3988 3989 3990 3991 3992 3993 3994 3995 ... 7860